Key points are not available for this paper at this time.
Nanoparticles are an essential component in the emerging field of nanomedical imaging and therapy. When deployed in vivo, these materials are typically protected from the immune system by polyethylene glycol (PEG). A wide variety of strategies to coat and characterize nanoparticles with PEG has established important trends on PEG size, shape, density, loading level, molecular weight, charge and purification. Strategies to incorporate targeting ligands are also prevalent. This article presents a background to investigators new to stealth nanoparticles, and suggests some key considerations needed prior to designing a nanoparticle PEGylation protocol and characterizing the performance features of the product.
Building similarity graph...
Analyzing shared references across papers
Loading...
Jesse V. Jokerst
Tatsiana Lobovkina
Richard N. Zare
Nanomedicine
Stanford University
Building similarity graph...
Analyzing shared references across papers
Loading...
Jokerst et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69d6f39de328128020aa88c6 — DOI: https://doi.org/10.2217/nnm.11.19
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: